Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients

Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation

(2021) Mario Leutert et al.   Frontiers in Immunology

The mutational constraint spectrum quantified from variation in 141,456 humans

(2020) Konrad J. Karczewski et al.   NATURE

Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39−CD73 signaling pathway

(2020) Junlong Dang et al.   JOURNAL OF AUTOIMMUNITY

Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus

(2020) Lennard Ostendorf et al.   NEW ENGLAND JOURNAL OF MEDICINE

dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs

(2020) Xiaoming Liu et al.   Genome Medicine

The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus

(2019) Marcus Tan et al.   Cells

Overview of the mammalian ADP-ribosyl-transferases clostridia toxin-like (ARTCs) family

(2019) Maria Di Girolamo et al.   BIOCHEMICAL PHARMACOLOGY

AMP and adenosine are both ligands for adenosine 2B receptor signaling

(2018) Jessica K. Holien et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Introduction: Posttranslational Protein Modification

(2018) Hening Lin et al.   CHEMICAL REVIEWS

Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity

(2018) Zhao-wei Gao et al.   IMMUNOLOGIC RESEARCH

Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach

(2018) Christopher M. Tipton et al.   IMMUNOLOGICAL REVIEWS

Pharmacology of Adenosine Receptors: The State of the Art

(2018) Pier Andrea Borea et al.   PHYSIOLOGICAL REVIEWS

Methotrexate mechanism in treatment of rheumatoid arthritis

(2018) Benjamin Friedman et al.   JOINT BONE SPINE

Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE)

(2017) William Stohl   Expert Review of Clinical Immunology

CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction

(2017) Julia Hesse et al.   FASEB JOURNAL

Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells

(2017) Yogita Ghodke-Puranik et al.   Arthritis & Rheumatology

Systemic lupus erythematosus

(2016) Arvind Kaul et al.   Nature Reviews Disease Primers

T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity

(2015) Vaishali R. Moulton et al.   JOURNAL OF CLINICAL INVESTIGATION

Diagnostic criteria for systemic lupus erythematosus: A critical review

(2014) Cong Yu et al.   JOURNAL OF AUTOIMMUNITY

Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5′-nucleotidase (CD73)

(2014) Natasha T. Snider et al.   MOLECULAR BIOLOGY OF THE CELL

Adenosine production by human B cells and B cell-mediated suppression of activated T cells

(2013) Z. Saze et al.   BLOOD

Regulation of Inflammation by Adenosine

(2013) György Haskó et al.   Frontiers in Immunology

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 after Ischemic Injury

(2012) Florian Bönner et al.   PLoS One

T cells as therapeutic targets in SLE

(2010) José C. Crispín et al.   Nature Reviews Rheumatology

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

(2008) György Haskó et al.   NATURE REVIEWS DRUG DISCOVERY